
The logo of Seven & I Holdings is seen at its headquarters in Tokyo, Japan.
11:20 JST, May 25, 2023
TOKYO (Jiji Press) — A partner of U.S. activist fund ValueAct Capital expressed confidence that shareholders of Japanese retailer Seven & i Holdings Co. will approve a proposal to remove Ryuichi Isaka as president.
The proposal from ValueAct Capital has garnered wide support among institutional investors both inside and outside Japan, Robert Hale, who is in charge of Japanese stock investment at the U.S. fund, said in a written interview with Jiji Press. Seven & i shareholders meet in Tokyo on Thursday. Over 90% of votes cast at the previous shareholders’ meeting supported Isaka.
Hale reiterated ValueAct Capital’s demand that Seven & i focus on the convenience store business.
Seven & i will miss its chance to grow unless it does selection and concentration, especially at a time when rivals focus on one business area, Hale said.
Seven & i currently operates its flagship Seven-Eleven convenience store chain, as well as supermarkets including struggling Ito-Yokado chain.
Hale said that supermarket operations will be better suited to meet local needs if they are cut off from the holding company.
Top Articles in Business
-
Nippon Life Insurance’s U.S. Arm Sues OpenAI Over Legal Assistance Provided by ChatGPT
-
Japan, U.S. Name 3 Inaugural Investment Projects; Reached Agreement After Considerable Difficulty
-
Japan’s Major Real Estate Firms Expanding Overseas Businesses to Secure Future Growth, Focusing on Europe, U.S., Asia
-
JR Tokai Breaks Ground on Yamanashi Maglev Station; Will Be Part of Linear Chuo Shinkansen Line from Tokyo to Nagoya
-
Transport Companies See Opportunity in Narita Expansion; Airlines, Railways Prepare to Meet Expected Growth in Demand
JN ACCESS RANKING
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Japan PM Takaichi’s Cabinet Resigns en Masse
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
Japan Figure Skating Legend Yuzuru Hanyu Is Proud Disaster Survivor and Gold Medalist, Vows to Continue Support Efforts
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed

